Investing Ideas
/
Italian Pharmaceuticals & Biotech Healthy potentially undervalued

Italian Pharmaceuticals & Biotech Healthy potentially undervalued

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are potentially undervalued and in an acceptable financial position.

1 companies

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.3b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

REC

€50.40

3.6%

4.2%